肝硬化患者剂量调整:两种建模方法的比较
该研究比较了生理药代动力学(PBPK)模型与基于健康志愿者全身清除率校正肝肾功能标志物的自上而下法,预测肝硬化患者六种探针药物AUC和清除率的能力;两种方法定性预测良好,PBPK法对药物暴露变化预测更准确。
要点
- PBPK与自上而下法对六种探针药在肝硬化患者的AUC和清除率预测多数在均值±2SD内。
- 除依非韦伦外,两种方法对总药和游离药浓度预测均落在均值±2SD内。
- 游离分数<50%的药物,用游离浓度预测比总浓度更准确。
核心结论
- PBPK法和自上而下法均能良好定性预测肝硬化对六种探针药物药代动力学的影响。
- PBPK法比自上而下法更准确地预测药物暴露变化,并提供可靠的血浆浓度估计。
研究设计与样本
- 比较两种建模方法:基于Simcyp的生理药代动力学(PBPK)法和基于健康志愿者全身清除率校正肝肾功能标志物的自上而下法。
- 研究对象为肝硬化患者和健康对照者,评估六种探针药物(咖啡因、依非韦伦、氟比洛芬、奥美拉唑、美托洛尔、咪达唑仑)的AUC和清除率预测。
主要发现
- 除少数例外,PBPK法准确预测了血浆浓度-时间曲线。
- 除依非韦伦外,两种方法对总药和游离药浓度的估计均在均值±2个标准差内。
- 使用调整剂量计算的AUC与对照者实测AUC相当,PBPK法预测略更准确。
- 对于游离分数<50%的药物,使用游离药物浓度的预测比总药物浓度更准确。
临床怎么用
- 两种方法均可用于肝硬化患者剂量调整的定性预测,PBPK法预测暴露变化更准确。
- 对于游离分数<50%的药物,建议使用游离药物浓度进行剂量调整预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Failure to perform adequate dose adjustment in patients with liver cirrhosis may be associated with increased toxicity. We compared the prediction of area under the curve (AUC) and clearance for the six compounds of the Basel phenotyping cocktail (caffeine, efavirenz, flurbiprofen, omeprazole, metoprolol, and midazolam) using a well-known physiology-based pharmacokinetic approach (physiologically-based pharmacokinetic [PBPK] approach, Simcyp) and a novel top-down method based on the systemic clearance in healthy volunteers adjusted for markers of liver and renal dysfunction ("top-down approach"). With few exceptions, plasma concentration-time curves were accurately predicted by the PBPK approach. In comparison to the measured AUC and clearance of these drugs in patients with liver cirrhosis and healthy controls, except for efavirenz, the estimates of both approaches were within two standard deviations of the mean for total and free drug concentrations. For both approaches, a correction factor for dose adjustment in patients with liver cirrhosis could be calculated for the drugs administered. AUCs calculated using the adjusted doses were comparable to the AUCs measured in control subjects, with slightly more accurate predictions generated by the PBPK approach. For drugs with a free fraction < 50%, predictions using free drug concentrations were more accurate than with total drug concentrations. In conclusion, both methods provided good qualitative predictions of the changes by liver cirrhosis in the pharmacokinetics of the six compounds investigated. The top-down approach is easier to implement but the PBPK approach predicted changes in drug exposure more accurately than the top-down approach and provided reliable estimates for plasma concentrations.
引用
- Ozbey AC, Bachmann F, Duthaler U, et al. Dose Adjustment in Patients with Liver Cirrhosis - Comparison of Two Different Modeling Approaches. Clin Pharmacol Ther. 2023. PMID: 37017611. doi:10.1002/cpt.2897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。